Diego Borges

Diego Borges-Rivera is a skilled computational biologist with extensive experience in the field, currently working at Vevo Therapeutics since September 2022 and concurrently at Dogodan Therapeutics, Inc. since August 2022. Prior roles include positions at Enko, Goldfinch Bio, and DeepBiome Therapeutics, where expertise in scRNA-seq data analysis and computational infrastructure was developed. Diego's academic background includes a PhD from the Massachusetts Institute of Technology, focusing on cis-regulatory elements and genome analysis, as well as a B.S. from Carnegie Mellon University in computational biology. Experience also includes positions at the Broad Institute and Carnegie Mellon University, enhancing a robust foundation in computational biology and data science.